Jonathan Macdonald

3PUBLICATIONS
32CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.

Neil Chanchlani, Simeng Lin, Marcus K Auth

|Sep 02, 2021
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.

Neil Chanchlani, Simeng Lin, Desmond Chee

|Apr 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.

Nicholas A Kennedy, Simeng Lin, James R Goodhand

Pageof 1

Frequent Collaborators

3 joint publications

Nicholas A Kennedy

3 joint publications

Simeng Lin

3 joint publications

James R Goodhand

3 joint publications

Neil Chanchlani